Damia G - Search Results

1

Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.

Ricci F, Fratelli M, Guffanti F, Porcu L, Spriano F, Dell'Anna T, Fruscio R, Damia G. Ricci F, et al. Among authors: damia g. Oncotarget. 2017 Jan 31;8(5):7441-7451. doi: 10.18632/oncotarget.7465. Oncotarget. 2017. PMID: 26910918 Free PMC article.

2

Unique features of the mode of action of ET-743.

D'Incalci M, Erba E, Damia G, Galliera E, Carrassa L, Marchini S, Mantovani R, Tognon G, Fruscio R, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: damia g. Oncologist. 2002;7(3):210-6. doi: 10.1634/theoncologist.7-3-210. Oncologist. 2002. PMID: 12065793 Free article. Review.

3

Improving the selectivity of cancer treatments by interfering with cell response pathways.

Damia G, Broggini M. Damia G, et al. Eur J Cancer. 2004 Nov;40(17):2550-9. doi: 10.1016/j.ejca.2004.07.020. Eur J Cancer. 2004. PMID: 15541958 Review.

4

Genetic instability influences drug response in cancer cells.

Damia G, D'Incalci M. Damia G, et al. Curr Drug Targets. 2010 Oct;11(10):1317-24. doi: 10.2174/1389450111007011317. Curr Drug Targets. 2010. PMID: 20840074 Review.

5

Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations.

Ganzinelli M, Mariani P, Cattaneo D, Fossati R, Fruscio R, Corso S, Ricci F, Broggini M, Damia G. Ganzinelli M, et al. Among authors: damia g. Eur J Cancer. 2011 May;47(7):1086-94. doi: 10.1016/j.ejca.2010.11.029. Epub 2011 Jan 7. Eur J Cancer. 2011. PMID: 21216588

6

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

Ricci F, Bernasconi S, Perego P, Ganzinelli M, Russo G, Bono F, Mangioni C, Fruscio R, Signorelli M, Broggini M, Damia G. Ricci F, et al. Among authors: damia g. Cell Cycle. 2012 May 15;11(10):1966-76. doi: 10.4161/cc.20308. Epub 2012 May 15. Cell Cycle. 2012. PMID: 22544328

7

Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo.

Carrassa L, Chilà R, Lupi M, Ricci F, Celenza C, Mazzoletti M, Broggini M, Damia G. Carrassa L, et al. Among authors: damia g. Cell Cycle. 2012 Jul 1;11(13):2507-17. doi: 10.4161/cc.20899. Epub 2012 Jul 1. Cell Cycle. 2012. PMID: 22713237

8

Revisiting ovarian cancer preclinical models: implications for a better management of the disease.

Ricci F, Broggini M, Damia G. Ricci F, et al. Among authors: damia g. Cancer Treat Rev. 2013 Oct;39(6):561-8. doi: 10.1016/j.ctrv.2013.01.005. Epub 2013 Feb 19. Cancer Treat Rev. 2013. PMID: 23434073 Review.

9

ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.

Ricci F, Bernasconi S, Porcu L, Erba E, Panini N, Fruscio R, Sina F, Torri V, Broggini M, Damia G. Ricci F, et al. Among authors: damia g. Am J Cancer Res. 2013 Apr 3;3(2):221-9. Print 2013. Am J Cancer Res. 2013. PMID: 23593543 Free PMC article.

10

Successes and limitations of targeted cancer therapy in ovarian cancer.

Damia G, Sessa C. Damia G, et al. Prog Tumor Res. 2014;41:89-97. doi: 10.1159/000355905. Epub 2014 Feb 17. Prog Tumor Res. 2014. PMID: 24727989 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters